Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
7.75
+0.44 (6.02%)
At close: Mar 9, 2026, 4:00 PM EDT
7.60
-0.15 (-1.94%)
After-hours: Mar 9, 2026, 5:03 PM EDT
Tevogen Bio Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 19.95 | 23.43 | 4.44 | 8.43 | 1.66 |
| Research & Development | 10.94 | 30.14 | 4.4 | 5.29 | 2.96 |
| Operating Expenses | 30.89 | 53.56 | 8.84 | 13.72 | 4.62 |
| Operating Income | -30.89 | -53.56 | -8.84 | -13.72 | -4.62 |
| Interest Expense | -0.14 | -0.18 | -1.21 | -0.93 | -0.6 |
| Interest & Investment Income | - | - | 0 | 0 | 0 |
| Other Non Operating Income (Expenses) | -0.01 | -0.95 | - | - | - |
| EBT Excluding Unusual Items | -31.04 | -54.7 | -10.05 | -14.66 | -5.22 |
| Merger & Restructuring Charges | - | -7.5 | - | - | - |
| Other Unusual Items | - | 48.47 | -50.43 | -7.38 | -10.38 |
| Pretax Income | -31.04 | -13.73 | -60.48 | -22.04 | -15.6 |
| Net Income | -31.04 | -13.73 | -60.48 | -22.04 | -15.6 |
| Preferred Dividends & Other Adjustments | 0.37 | -3.45 | - | - | - |
| Net Income to Common | -31.42 | -10.27 | -60.48 | -22.04 | -15.6 |
| Shares Outstanding (Basic) | 3 | 3 | 0 | 1 | 1 |
| Shares Outstanding (Diluted) | 3 | 3 | 0 | 1 | 1 |
| Shares Change (YoY) | 32.33% | 492.57% | -1.98% | 0.69% | - |
| EPS (Basic) | -9.41 | -3.50 | -122.17 | -43.64 | -31.09 |
| EPS (Diluted) | -9.41 | -3.50 | -122.17 | -43.64 | -31.09 |
| Free Cash Flow | -13.19 | -12 | -8.3 | -9.13 | -5.38 |
| Free Cash Flow Per Share | -3.95 | -4.09 | -16.77 | -18.09 | -10.73 |
| EBITDA | -30.72 | -53.4 | -8.68 | -13.63 | -4.61 |
| D&A For EBITDA | 0.17 | 0.16 | 0.16 | 0.09 | 0.01 |
| EBIT | -30.89 | -53.56 | -8.84 | -13.72 | -4.62 |
Source: S&P Capital IQ. Standard template.
Financial Sources.